Abstract:BACKGROUND:The association between Killer cell lectin like receptor B1 (KLRB1) and cancer has been reported, but the roles of KLRB1 in breast invasive carcinoma (BRCA) has not been fully revealed.METHODS:Our study utilized the Cancer Genome Atlas (TCGA), Kaplan-Meier (K-M) Plotter, and TIMER databases to investigate the expression and clinical relevance of KLRB1 in BRCA and to explore its roles and mechanism in BRCA progression using gene set enrichment analysis, CCK-8, migration, apoptosis, and western blotting. We examined the relationship between KLRB1 expression and the BRCA immune microenvironment, using data from TCGA, and Gene Expression Profiling Interactive Analysis (GEPIA) databases and validated these findings in K-M Plotter databases.RESULTS:A significant decrease of KLRB1 expression was observed in BRCA patients. BRCA patients with low KLRB1 levels were associated with older age, advanced disease stage, HER2-positivity, poor prognosis, and a decreased survival probability compared to the high-expression group. Increased KLRB1 expression levels were correlated with inhibition of breast cancer cell proliferation, migration, and invasion, as well as promotion of cell apoptosis, possible through regulation of the NF-κB, PI3K/AKT, and TNF signaling pathways. Moreover, the study also indicated that decreased KLRB1 expression correlated with tumor purity, immune score, and immune cell infiltration (B cells, CD8+ T cells, CD4+ T cells, neutrophils, dendritic cells, among others), cell markers, and immunotherapy.CONCLUSION:Decreased KLRB1 expression in BRCA is associated with poor prognosis and immune microenvironment. This study also highlights KLRB1 as a potential molecular marker for poor prognosis in BRCA patients, and therefore, it may provide clinical implications for the management of patients with BRCA.

Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB

HBXIP Induces Anoikis Resistance by Forming a Reciprocal Feedback Loop with Nrf2 to Maintain Redox Homeostasis and Stabilize Prdx1 in Breast Cancer

XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype.

Data from XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6

NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells

Notch-1 Signaling Activates NF-κB in Human Breast Carcinoma MDA-MB-231 Cells Via PP2A-dependent AKT Pathway

Inhibiting KLRB1 Expression is Associated with Impairing Cancer Immunity and Leading to Cancer Progression and Poor Prognosis in Breast Invasive Carcinoma Patients.

Negative Regulation Of Akt Activation By Brca1

Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer Through NF-κB Activation

Pan-cancer analysis reveals a regulatory pattern of anoikis in human cancers

Non-canonical Phosphorylation of Bmf by P38 MAPK Promotes Its Apoptotic Activity in Anoikis.

Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die

NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway

ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and C-Myc to reduce breast cancer proliferation.

Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer

ANKRD1 Promotes Breast Cancer Metastasis by Activating NF- κ B-MAGE-A6 Pathway

Influence of p75NTR ICD on anoikis resistance of tumor cells through activating NF-κB

Data from the Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer

IKKβ Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells.

Anoikis-related Signature Identifies Tumor Microenvironment Landscape and Predicts Prognosis and Drug Sensitivity in Colorectal Cancer.

Regulation of anoikis by extrinsic death receptor pathways